Skip to ContentGo to accessibility page

Chapter 12

Review Questions

1.
a. Mannitol is administered for cerebral edema and increased intracranial pressure. Elevating the head of the bed to a 30-degree angle and keeping the client’s head in a neutral position helps to decrease intracranial pressure.
2.
c. 300 mg x mL desired dose = 250 mg 5 mL supply on hand
250 x = 300 ( 5 ) x = 1500 250 x = 6 mL per dose .
3.
b. Sumatriptan is contraindicated in pregnancy, and contraception should be taken while on this drug.
4.
a. Valproic acid is a valproate, which is used in the treatment of seizures and as a mood stabilizer.
5.
b. 70 mg x mL desired dose = 50 mg 1 mL supply on hand
50 x = 70 ( 1 ) x = 70 50 x = 1.4 mL per dose .
6.
d. Rash is an adverse effect of ethosuximide.
7.
b. Migraine headache symptoms can last for several hours up to several days.
8.
d. The normal intracranial pressure for a client in a vertical position is 7–15 mm Hg.
9.
a. Acetazolamide is an osmotic diuretic and is used in the treatment of cerebral edema, intracranial hypertension, and to lower increased intracranial pressure.
10.
d. Levetiracetam is used in the treatment of seizures and causes adverse effects such as behavioral symptoms of hostility and aggression as well as psychotic symptoms of hallucinations and delirium.
Citation/Attribution
Reuse and redistribution of this content in digital or print format:
  • This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's prior written permission.
  • This book uses the Creative Commons Attribution-NonCommercial-ShareAlike License, which means that you can reuse and modify the material only for noncommercial purposes, must attribute OpenStax, and must distribute any derivative works under the same license.
  • Any commercial printing of this textbook, including using a local or custom printer, must be approved by OpenStax, and proper citation provided.
  • OpenStax-copyrighted images, activities, assessments, and similar components of this book are subject to the same licensing – CC-BY-NC-SA. They can be used for noncommercial purposes with attribution. Commercial use requires permission.
  • Permission requests: Anyone who intends to incorporate this content (including text, images, and other components) into large language models, use it in AI offerings, use it commercially (including in print), and/or has questions about another use case is welcome to complete our reuse request form.
Attribution information
  • If you are redistributing all or part of this book in a noncommercial print format, then you must include on every physical page the following attribution:

    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction

  • If you are redistributing all or part of this book in a noncommercial digital format, then for every page that includes OpenStax content, you must license the derivative work under the same CC-BY-NC-SA license as the original, and include on every digital page view the following attribution:

    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction

Citation information

The information below includes the information needed to generate citations in most major styles (APA, MLA, etc.); you must reformat and organize the information as needed to fit the requirements of the style. Use the information below to generate a citation. We recommend using a citation tool such as this one.

© Apr 23, 2026 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo, and Rice University name, and Rice University logo trademarks, or wordmarks are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.